论文部分内容阅读
目的分析尼莫地平治疗脑出血后缺血性脑损伤的临床效果。方法 80例脑出血后缺血性脑损伤患者,随机分为观察组和对照组,每组40例。观察组使用尼莫地平口服治疗,对照组使用依达拉奉进行静脉推注治疗,比较两组患者的综合临床疗效。结果在治疗完成后,观察组的总有效率明显高于对照组,观察组中的不良反应发生率明显低于对照组,差异均具有统计学意义(P<0.05)。治疗后,观察组神经功能缺损评分比对照组低(P<0.05)。两组均未产生明显的药物不良反应。结论使用尼莫地平治疗脑出血后缺血性脑损伤的临床效果更为显著,且患者恢复更为良好,可在临床进一步推广。
Objective To analyze the clinical effect of nimodipine on ischemic brain injury after intracerebral hemorrhage. Methods 80 cases of cerebral hemorrhage after ischemic brain injury were randomly divided into observation group and control group, 40 cases in each group. The observation group was treated with nimodipine orally, while the control group was treated with edaravone intravenously. The comprehensive clinical efficacy was compared between the two groups. Results After the treatment was completed, the total effective rate of the observation group was significantly higher than that of the control group. The incidence of adverse reactions in the observation group was significantly lower than that of the control group (P <0.05). After treatment, the score of neurological deficit in the observation group was lower than that of the control group (P <0.05). Two groups did not produce significant adverse drug reactions. Conclusion The clinical effect of nimodipine in the treatment of ischemic brain injury after intracerebral hemorrhage is more obvious, and the patients recover more well and can be further popularized in clinic.